PRODUCT Hotline

Published Online: Wednesday, October 1, 2008

Lamotrigine Tablets

Lamotrigine Tablets, manufactured by Teva Pharmaceuticals (North Wales, PA), are indicated as adjunctive therapy for partial seizures and the generalized seizures of Lennox–Gastaut syndrome in adults and pediatric patients (≥2 years of age). The tablets also are indicated for conversion to monotherapy in adults with partial seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. The product is AB-rated and bioequivalent to Lamictal Tablets (GlaxoSmithKline).

For More Information:
www.tevausa.com
888-TEVA USA (888-838-2872)



1500PRO Ultra Premium Blood Pressure Monitor

The 1500PRO Ultra Premium Blood Pressure Monitor with no wrap cuff, manufactured by Omron Healthcare (Bannockburn, IL), is an automatic cuff model that fits regular and large arms. The blood pressure monitor detects morning hypertension and irregular heartbeat; features memory for 2 users and a total of 200 measurements, and provides morning and evening averaging. The product also comes with Intellisense technology that applies the correct amount of pressure for fast, accurate, and more comfortable readings.

For More Information:
www.omronhealthcare.com



SyrSpend SF

active powders and oral solid dosage forms into a liquid suspension. It saves time during compounding. In addition, the product is buffered to pH 4.2 for enhanced compatibility and has a very low osmolality, making it suitable for pediatric and geriatric patients. The sugar-free SyrSpend SF is available in unflavored, cherry, and grape formulations.

For More Information:
www.gallipot.com
800-423-6967





Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A